Lyfegen Raises $8M for Value-Based Contracting for High-Cost Drugs
HIT Consultant
SEPTEMBER 20, 2022
Currently, less than 2% of the health insurance population requiring specialty drugs is responsible for 51% of drug spending. By 2025, total net spending on medicine in the US is expected to reach up to $400B. Value-Based Contracting.
Let's personalize your content